Evidence map›Paper›PMID 31572283›Full record

ReviewFrontiers in neurology2019

Methylphenidate Treatment of Cognitive Dysfunction in Adults After Mild to Moderate Traumatic Brain Injury: Rationale, Efficacy, and Neural Mechanisms.

Harvey Levin, Maya Troyanskaya, JoAnn Petrie, Elisabeth A Wilde, Jill V Hunter, Tracy J Abildskov, Randall S Scheibel

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Methylphenidate for neurological improvement post-TBI.Journal of family medicine and primary care · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Traumatic brain injury and mood disorders.The mental health clinician · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Harvey LevinDepartment of Physical Medicine & Rehabilitation, Baylor College of Medicine, Houston, TX, United States.
Maya TroyanskayaDepartment of Physical Medicine & Rehabilitation, Baylor College of Medicine, Houston, TX, United States.
JoAnn PetrieDepartment of Neurology, University of Utah, Salt Lake City, UT, United States.
Elisabeth A WildeDepartment of Physical Medicine & Rehabilitation, Baylor College of Medicine, Houston, TX, United States.
Jill V HunterBaylor College of Medicine, Texas Children's Hospital, Houston, TX, United States.
Tracy J AbildskovDepartment of Neurology, University of Utah, Salt Lake City, UT, United States.
Randall S ScheibelDepartment of Physical Medicine & Rehabilitation, Baylor College of Medicine, Houston, TX, United States.
Baylor College of Medicine · USMichael E. DeBakey VA Medical Center · USUniversity of Utah · USTexas Children's Hospital · US

Funding

An fMRI Study of Executive Functioning after TBIR01NS042772 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI LEVIN, HARVEY · 2001 to 2005
$4.4M
Cognitive control-related brain activation in veterans and service members with PTSDI01CX001820 · VA · MICHAEL E DEBAKEY VA MEDICAL CENTER · PI SCHEIBEL, RANDALL S. · 2019 to 2023
–
A longitudinal study of chronic TBI in OEF/OIF/OND Veterans and service membersI01RX001062 · VA · MICHAEL E DEBAKEY VA MEDICAL CENTER · PI SCHEIBEL, RANDALL S., WILDE, ELISABETH A · 2015 to 2018
–
CSRD VA I01 CX001820NINDS NIH HHS R01 NS042772RRD VA I01 RX001062
6 · The paper itself

Abstract

Positive effects of methylphenidate (MPH) on attention and cognitive processing speed have been reported in studies of patients with moderate to severe traumatic brain injury (TBI). Studies which have acquired functional brain imaging before and while using MPH have also found alteration of brain activation while performing a cognitive task; in some studies, this alteration of activation in selective brain regions was also related to improved performance on cognitive tests administered outside of the scanning environment. Enhanced cognitive performance has been reported after single doses of MPH and after daily treatment over durations of up to and exceeding 1 month. Preclinical research and both positron emission tomography and single photon emission tomography of humans have shown that MPH increases extracellular dopamine and norepinephrine; the dose effects of MPH have an inverted

Indexed as

clinical trialscognitiondopamineimagingmethylphenidatetraumatic brain injury

Identifiers

PMID31572283
PMCPMC6751302
OpenAlexW2967586145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.